107 related articles for article (PubMed ID: 11068834)
1. Endoscopic ultraviolet-induced autofluorescence spectroscopy of the esophagus: tissue characterization and potential for early cancer diagnosis.
Bourg-Heckly G; Blais J; Padilla JJ; Bourdon O; Etienne J; Guillemin F; Lafay L
Endoscopy; 2000 Oct; 32(10):756-65. PubMed ID: 11068834
[TBL] [Abstract][Full Text] [Related]
2. Optimized endoscopic autofluorescence spectroscopy for the identification of premalignant lesions in Barrett's oesophagus.
Holz JA; Boerwinkel DF; Meijer SL; Visser M; van Leeuwen TG; Aalders MC; Bergman JJ
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1442-9. PubMed ID: 24064569
[TBL] [Abstract][Full Text] [Related]
3. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
4. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
6. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
7. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
8. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Brand S; Wang TD; Schomacker KT; Poneros JM; Lauwers GY; Compton CC; Pedrosa MC; Nishioka NS
Gastrointest Endosc; 2002 Oct; 56(4):479-87. PubMed ID: 12297761
[TBL] [Abstract][Full Text] [Related]
9. [Surveillance of patients with Barrett's esophagus].
Endlicher E; Knüchel R; Messmann H
Z Gastroenterol; 2001 Aug; 39(8):593-600. PubMed ID: 11558064
[TBL] [Abstract][Full Text] [Related]
10. [Fluorescence diagnostics of premalignant and malignant changes in patients with Barrett's esophagus: doubts and hopes].
Sieroń A; Niepsuj K; Niepsuj G
Pol Merkur Lekarski; 2001 Dec; 11(66):467-71. PubMed ID: 11899839
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue chromoendoscopy for the detection of Barrett's esophagus in a Greek cohort.
Kouklakis GS; Kountouras J; Dokas SM; Molyvas EJ; Vourvoulakis GP; Minopoulos GI
Endoscopy; 2003 May; 35(5):383-7. PubMed ID: 12701007
[TBL] [Abstract][Full Text] [Related]
12. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
13. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
14. [Barrett's esophagus: endoscopic treatment of high-grade dysplasia and early cancer].
Bergman JJ; Marsman WA; Krishnadath KK; Fockens P; van Lanschot JJ; Tytgat GN
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2275-81. PubMed ID: 14655293
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study.
Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV
Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755
[TBL] [Abstract][Full Text] [Related]
17. Acetic acid allows effective selection of areas for obtaining biopsy samples in Barrett's esophagus.
Vázquez-Iglesias JL; Alonso-Aguirre P; Diz-Lois MT; Vázquez-Millán MA; Alvarez A; Lorenzo MJ
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):187-93. PubMed ID: 17301644
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis.
Ngamruengphong S; Sharma VK; Das A
Gastrointest Endosc; 2009 May; 69(6):1021-8. PubMed ID: 19215918
[TBL] [Abstract][Full Text] [Related]
19. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
[TBL] [Abstract][Full Text] [Related]
20. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
